» Articles » PMID: 20096725

Comparison of Chitosan/siRNA and Trimethylchitosan/siRNA Complexes Behaviour in Vitro

Overview
Publisher Elsevier
Date 2010 Jan 26
PMID 20096725
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Chitosan and trimethylchitosan (TMC)-siRNA nanoparticles were produced by simple complexation technique or by ionic gelation using tripolyphosphate (TPP). The obtained complexes were characterized in terms of physicochemical properties such as size, zeta potential, complexation efficiency and stability. Furthermore, cytotoxicity, cell uptake and transfection efficiency of polyplexes were evaluated in vitro. Under pH condition of cell culture medium, a strong decrease in siRNA condensation efficiency was observed with chitosan nanoparticles. This characteristic resulted in low transfection efficiencies in HEK293 cell line. Formulation of chitosan polyplexes with TPP led to improvement of polyplexes stability but no significant increase in transfection efficiency was observed compared to simple chitosan complexes. By contrast, TMC complexes did not have pH dependency on siRNA complexation. TMC-siRNA nanoparticles were stable in physiological condition. Accordingly, cellular uptake was increased compared to chitosan polyplexes. However, improvement of transfection efficiency was low regarding to cellular uptake of these complexes. Chitosan and TMC complexes present some characteristics favourable for siRNA delivery, such as ability to integrate siRNA into small discrete particles or low toxicity of the complexes. This study also highlights the importance of complexes stability in physiological environment for siRNA transfection purposes.

Citing Articles

Effect of Polyplex Size on Penetration into Tumor Spheroids.

Casadidio C, Hartman J, Mesquita B, Haegebaert R, Remaut K, Neumann M Mol Pharm. 2023; 20(11):5515-5531.

PMID: 37811785 PMC: 10630948. DOI: 10.1021/acs.molpharmaceut.3c00397.


Formulation of Apigenin-Cyclodextrin-Chitosan Ternary Complex: Physicochemical Characterization, In Vitro and In Vivo Studies.

Jafar M, Khalid M, Alghamdi H, Amir M, Al Makki S, Alotaibi O AAPS PharmSciTech. 2022; 23(2):71.

PMID: 35146576 DOI: 10.1208/s12249-022-02218-8.


Cyclodextrin Multicomponent Complexes: Pharmaceutical Applications.

Aiassa V, Garnero C, Longhi M, Zoppi A Pharmaceutics. 2021; 13(7).

PMID: 34371790 PMC: 8309128. DOI: 10.3390/pharmaceutics13071099.


Efficient inhibition of uveal melanoma via ternary siRNA complexes.

Xie L, Yang Y, Shen J Int J Pharm. 2019; 573:118894.

PMID: 31765784 PMC: 6954003. DOI: 10.1016/j.ijpharm.2019.118894.


Recent Advances in Chitosan-Based Carriers for Gene Delivery.

Cao Y, Tan Y, Wong Y, Jie Liew M, Venkatraman S Mar Drugs. 2019; 17(6).

PMID: 31242678 PMC: 6627531. DOI: 10.3390/md17060381.